| WDFY3-AS2 | lung adenocarcinoma | qPCR, Western blot, Luciferase reporter assay, RIP etc | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 32275336 | 2020 |
| WDFY3-AS2 | esophageal cancer | RNA-seq | L | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✔ | ✘ | 30972633 | 2019 |
| WDFY3-AS2 | breast cancer | qPCR | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 30959550 | 2019 |
| WDFY3-AS2 | ovarian cancer | qPCR, Western blot, Luciferase reporter assay, RIP | L | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 31347170 | 2019 |
| WDFY3-AS2 | hepatocellular carcinoma | qPCR, RNAi, Cell proliferation assay, Cell migration assay etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 28194035 | 2017 |
| WDFY3-AS2 | Ovarian cancer | qRT-PCR;luciferase reporter assays;Western blot | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 34051810 | 2021 |